4 results
P
human subjects
I/C
exposure to light at night (LAN), none
O
risk of obesity, overweight, body mass index (BMI), waist circumference, waist-hip-ratio, waist-to-height-ratio
P
breast cancer patients
I/C
exposure to light at night (LAN), assessment of LAN using satellite data
O
risk estimates of breast cancer
P
E2F4, FOXM1, TFDP1, E2F1, SIN3A, JUN, DDX4, FOSL1, NOC2L, HMGA1, CDK1, CCNB1, AURKA, CDC20, CCNA2, SCNN1A, CDCA3, SOX6
I/C
O
survival prognosis, immune infiltrations, diagnostic efficacy
P
8050 patients
I/C
Cyclosporine + methotrexate + Anti-T cell globulin (ATG), tacrolimus + methotrexate + ATG, tacrolimus + bortezomib + sirolimus, cyclosporine + marrow mesenchymal stem cells (MMSCs), corticosteroids alone
O
proportion of patients who respond to therapies
